PMCCPMCCPMCC

Conseils de recherche
Les critères de recherche 

Avancée

 
Logo of frontimmuLink to Publisher's site
 
Front Immunol. 2017; 8: 204.
Published online 2017 March 3. doi:  10.3389/fimmu.2017.00204
PMCID: PMC5334638

T Cell Receptor and Cytokine Signaling Can Function at Different Stages to Establish and Maintain Transcriptional Memory and Enable T Helper Cell Differentiation

Abstract

Experienced T cells exhibit immunological memory via a rapid recall response, responding to restimulation much faster than naïve T cells. The formation of immunological memory starts during an initial slow response, when naïve T cells become transformed to proliferating T blast cells, and inducible immune response genes are reprogrammed as active chromatin domains. We demonstrated that these active domains are supported by thousands of priming elements which cooperate with inducible transcriptional enhancers to enable efficient responses to stimuli. At the conclusion of this response, a small proportion of these cells return to the quiescent state as long-term memory T cells. We proposed that priming elements can be established in a hit-and-run process dependent on the inducible factor AP-1, but then maintained by the constitutive factors RUNX1 and ETS-1. This priming mechanism may also function to render genes receptive to additional differentiation-inducing factors such as GATA3 and TBX21 that are encountered under polarizing conditions. The proliferation of recently activated T cells and the maintenance of immunological memory in quiescent memory T cells are also dependent on various cytokine signaling pathways upstream of AP-1. We suggest that immunological memory is established by T cell receptor signaling, but maintained by cytokine signaling.

Keywords: chromatin, enhancer, epigenetics, gene regulation, immunological memory, T cells, transcription

Introduction

The adaptive immune system relies on both specific antigen (Ag) recognition and on the ability of lymphocytes to maintain a memory of previous encounters with Ags. These two features represent the essential basis of acquired immunity. The capacity of the immune system to recognize billions of epitopes is established via the complex process of Ag receptor gene recombination that produces countless combinations of specificities for foreign Ags. The ability of T cells to respond faster and more efficiently to weaker stimuli is supported by memory T cells which exhibit what is referred to as a rapid recall response (110). What was until recently not so well defined are the molecular mechanisms that actually allow memory T cells to respond much more rapidly to re-exposure to the same Ags. Recent studies have now shown that the acquisition of T cell-dependent memory is supported by the epigenetic reprogramming of the genome via T cell receptor (TCR) signaling. Activation of the TCR triggers a hit-and-run mechanism whereby a single cycle of activation leads to the acquisition of thousands of stably maintained active chromatin regions which include many of the inducible immune response genes that deliver effective immune responses (10). Active chromatin priming is now known to be one of several parallel mechanisms employed by activated T cells and memory T cells to enable the rapid expression of immune response factors. It is also established that activated T cells induce cytokine or chemokine production by virtue of enhanced TCR signaling (11, 12), loss of repressive chromatin modifications (1315), increased mRNA stability (16), and more efficient translation of cytokine mRNAs (17). However, some of these mechanisms are only relevant for a subset of immune response genes (18), whereas active chromatin modifications represent a more universal mechanism of maintaining immunological memory throughout the T cell compartment (10). In this review, we will focus on just the role of active chromatin priming in T cells and present some new analyses of previously published data to illustrate the potential of TCR-inducible chromatin priming in underpinning the subsequent stages of T cell differentiation.

T Cell Activation and Differentiation

Mature T cells exit the thymus with all the genetic components needed to recognize Ags. However, what these naïve T cells lack is the ability to respond rapidly to their first encounter with the Ags recognized by their specific TCRs. During a productive immune response, when naïve T cells are first activated, they require correct Ag presentation over an extended period of time (~1 to 2 days) as they undergo the complex process of blast cell transformation. During this process they convert from small quiescent cells to larger highly proliferative cells (Figure (Figure1A).1A). Depending upon the nature of the Ag and the cytokine milieu in the environment where they reside, recently activated T cells can undergo further differentiation steps giving rise to different sub-types of effector T cells, expressing different combinations of immune response genes (1922). For example, under the influence of IL-12 and STAT4, naïve CD4 cells tend to differentiate into type 1 helper (Th1) cells which can express inducible genes such as IFNG and GZMB which are activated via cooperation between the transcription factor (TF) TBX21 (T-Bet) and TCR-inducible TFs (Figure (Figure1A).1A). Conversely, IL-4 and STAT6 signaling in CD4 T cells triggers differentiation into type 2 helper (Th2) cells expressing TCR-inducible genes such as IL4 which are activated by the TF GATA3. Recently activated T blast cells and differentiated T cells remain tightly regulated and rely on ongoing activation of TCR signaling to express inducible immune response genes (18).

Figure 1
T cell activation pathways linked to immunological priming. (A) Naïve T cells are transformed by T cell receptor (TCR) signaling, leading to cytokine-dependent proliferation and differentiation, before reverting to quiescent memory T cells. (B,C) ...

The Basis of the Rapid Recall Immunological Response in Memory T Cells

Once an immune response has been resolved, the vast majority of activated T cells die. However, a small proportion of cells return to the quiescent state as Ag-specific memory T cells. Unlike naïve T cells, memory T cells are primed and ready to respond to any new encounter with the same Ag. Indeed, a defining feature that memory T cells share with recently activated T blast cells is that they are capable of responding to TCR signaling to activate hundreds of immune response genes within 1–2 h (Figure (Figure1B),1B), whereas naïve T cells typically take about 24 h to mount a full response (Figure (Figure1C)1C) (10). The process of T blast cell transformation, which is required to make the rapid recall response possible, involves extensive chromatin remodeling, whereby the Brg1 SWI/SNF family chromatin remodeling complex mediates epigenetic reprogramming of the genome to prime inducible loci for transcriptional reactivation (24). This hit-and-run mechanism, triggered by TCR signaling, establishes thousands of open chromatin regions embedded within extensive active chromatin domains (10, 18). Once formed, these primed regions are stably maintained by mechanisms independent of TCR signaling. Indeed, hit-and-run mechanisms of chromatin priming are widely used in eukaryotes from plants to animals to maintain transcriptional memory (2529). An example of this is found in previously activated macrophages which maintain regions marked by histone methylation in the vicinity of inducible enhancers (30).

Defining the Epigenetic Landscape in T Cells

Studies of chromatin architecture and analyses of TF binding within chromatin have always played a major role in studies of gene regulation and genome function (3137). These studies have collectively shown that active gene promoters and transcriptional enhancers typically exist as accessible nucleosome-free regions known as DNase I hypersensitive sites (DHSs) (31, 37). When active, these open regions are also normally flanked by nucleosomes carrying activating chromatin modifications such as acetylation and methylation of specific lysines in the histone tails (3639). Active enhancer elements are typically associated with mono- and di-methylation of lysine 4 and acetylation of lysine 27 in the histone H3 tail (H3K4me1/2 and H3K27ac) (37, 39). Analyses of epigenetic mechanisms are now routinely done globally, and high-throughput sequencing technologies make it straightforward to perform complex integrated chromatin and gene regulation analyses on a genome-wide basis. By sequencing small DNA fragments released from DHSs by DNase I (DNase-Seq) or transposase (ATAC-Seq) (40), and DNA fragments cross-linked to immunoprecipitated TFs or modified histones (ChIP-Seq) (Figure (Figure2)2) it is possible to define complex gene regulation networks (41).

Figure 2
The basis of epigenetic profiling of DNase I hypersensitive sites (DHSs) by DNase-Seq and ChIP-Seq. Active gene regulatory elements that exist as open chromatin regions can be identified in a genome-wide manner by DNA sequencing of either (1) DNA fragments ...

Previous studies in a multitude of model systems have reported that gene loci can be activated in a step-wise manner whereby DHSs are acquired in a defined sequence as cells follow a specific differentiation pathway. Interestingly, this leads to the acquisition of some DHSs which are associated with genes that exist in a transcriptionally competent but inactive state. Examples of DHSs that are acquired through differentiation are observed when CD4 T cells are polarized to alternate fates as Th1 and Th2 cells. Hence, Th1-specific DHSs are associated with binding of TBX21 at the Th1 gene IFNG, and Th2-specific DHSs associated with GATA3 binding at the Th2 gene IL4 (42). The DHSs in these cells are also associated with STAT proteins in a cell type-specific manner. STAT4 and STAT6 binding is observed at the DHSs in Th1 and Th2 cells, respectively (43, 44). However, in addition to differentiation-specific DHSs, CD4 T cells acquire many DHSs in genes such as IL4 in recently activated T cells prior to terminal differentiation (10, 42). These newly acquired DHSs represent the early stages of acquiring transcriptional competency prior to the activation of active transcription (18, 23, 45).

It is also well established that extensive histone methylation and acetylation exists at genes poised for reactivation in T cells (8, 9, 4648). Some genes in T cells exist in a poised state maintained by H3K4 di- or tri-methylation which is established by trithorax family SET domain proteins (28, 49, 50). In memory T cells, a proportion of immune response genes have their promoters marked by H3K4me3, whereas these genes are associated with repressive H3K27me3 modifications introduced by polycomb group complexes in naïve T cells (13, 46, 5156). Both CD4 and CD8 memory T cells retain extensive histone acetylation and low levels of DNA methylation at immune response genes (48, 5763). This is in contrast to the higher levels of DNA methylation observed in naïve T cells (14, 15, 42, 58, 61, 64). These epigenetic differences between naïve and memory T cells suggest that in memory T cells, immune response genes are maintained in a primed conformation. However, it was not always clear how these various chromatin states were targeted to specific loci at the various stages or how they were maintained. With the exception of the loss of DNA methylation, which represents a logical target for hit-and-run mechanisms of locus activation, active chromatin states typically rely on the continued presence of specific activating TFs. In the case of memory T cells, the specific factors responsible for maintaining chromatin priming were until recently poorly defined.

Global Analysis of Chromatin Priming in Previously Activated T Cells

To gain a greater understanding of epigenetic priming in T cells, we recently embarked on an in depth study of the chromatin modifications are first acquired occur during T blast cell transformation and are then maintained in differentiated T cells and memory T cells (10). By identifying all of the DHSs that are present in recently activated murine CD4 T blast cells and CD4 memory T cells, but not in naïve CD4 T cells, we identified ~3,000 newly acquired and stably maintained primed DHSs (pDHSs) that could potentially account for immunological memory in T cells (Figures (Figures3A,B)3A,B) (10). These DHSs fulfilled some of the essential features needed for a priming mechanism, because they supported the maintenance of domains of active chromatin modified by H3K4me2 and H3K27ac without having any significant impact on steady-state levels of transcription (10, 18) (Figure (Figure3B).3B). Consistent with this, transcriptional memory has been associated with a retention of H3K4me2 in other systems (27, 65).

Figure 3
Identification of distinct subsets of primed DHSs (pDHSs) and inducible DHSs (iDHSs) in mouse T cells by DNase-Seq and ChIP-Seq. (A) Genome-wide profiling of pDHSs enriched in CD4+ T blast cells relative to naïve T cells (10). Profiles are shown ...

Significantly, the primed active domains seen in T cells often encompassed inducible DHSs (iDHSs) which are known to function in the TCR-dependent activation of immune response genes. The inducible enhancers associated with these pDHSs included those which regulate genes encoding the inducible cytokines IL-3, GM-CSF (CSF2), IL-13, and IL-4 (10, 23, 6668). These enhancers are included in a population of several thousand highly iDHSs, which are closely associated with inducible genes in recently activated T blast cells (Figure (Figure3C).3C). The inducible nature of these loci is depicted here as a heat map showing the relative change in mRNA for the nearest gene to each iDHS following stimulation.

Somewhat paradoxically, pDHSs and iDHSs generally recruit the same classes of TFs, but in different proportions (Figure (Figure3D).3D). However, this makes perfect sense given that there is no substantial change in the TF repertoire immediately following T blast cell transformation, but only later in the differentiation process (Figure (Figure1A).1A). The iDHSs are highly enriched with binding sites for the TCR-inducible TFs NFAT and AP-1 (Figures (Figures3C,D),3C,D), as well as motifs for EGR and NF-kB family TFs which can be induced via multiple signaling pathways (10). More than half of these NFAT and AP-1 motifs exist as composite NFAT/AP-1 motifs, which are known to support cooperative binding of NFAT and AP-1, as previously described for the IL-2 promoter and the GM-CSF enhancer (69, 70). When aligned with the iDHSs, the AP-1 and AP-1/NFAT motifs are heavily concentrated in the inducible population, and they recruit the AP-1 protein JUNB upon stimulation (Figure (Figure3C).3C). By contrast, the pDHSs encompass far fewer AP-1 motifs (Figure (Figure3D),3D), but nevertheless they still contain significantly more AP-1 sites than the other constitutive DHSs shared with naïve T cells (Figure (Figure3A).3A). Importantly, the AP-1 motifs in pDHSs can recruit the AP-1 TF JUNB, but only in response to stimulation (Figure (Figure3A).3A). The pDHSs are principally defined by the high density of RUNX1 and ETS-1 motifs, whereas they have a much lower density of inducible binding sites. Although they lack NFAT sites, subsets of these elements retain the ability to respond to various signaling pathways as they include motifs for STAT, AP-1, and IRF family TFs, and for the STAT6-inducible TF GATA3 (Figure (Figure3D).3D). The iDHSs also respond by recruiting constitutive TFs such as RUNX, but unlike the pDHSs, they lose binding of RUNX1 once the inducible factors have gone.

Studies of the Th2 Cytokine Gene Locus as a Model for Chromatin Priming

The Th2 cytokine gene cluster encompassing Il4, Il13, and Il5 (Figure (Figure4)4) represents an ideal model for depicting the key features of the pDHSs and iDHSs at the different stages of T cell activation, expansion, and differentiation illustrated above in Figure Figure1A.1A. These genes reside within a 145 kb chromatin domain demarcated by two prominent binding sites for the insulator factor CTCF which may represent chromatin boundaries, as previously shown for a cluster of CTCF sites in the IL3/CSF2 locus (71). The Th2 cytokine gene locus is controlled by a single locus control region (LCR) which resides within the Rad50 gene between Il13 and Il5 (72, 73). Significantly, with the exception of the Rad50 promoter, this entire 145 kb chromatin domain exists in an inaccessible and unmodified state in naïve T cells, as measured by DNase-Seq and H3K4me2 and H3K27ac ChIP-Seq (Figure (Figure4).4). By contrast, the Irf1 chromatin domain downstream of the 3′ CTCF site is packed with constitutive DHSs in both naïve T cells and T blast cells.

Figure 4
Profiling of epigenetic modifications in the mouse type 2 helper cytokine gene cluster by DHS-Seq and ChIP-Seq. Profiles are based on published data from naïve, blast, and memory T cells (10) and include published data for CTCF ChIP-Seq from splenocytes ...

After a cycle of TCR activation and blast cell transformation, actively dividing T blast cells cultured in IL-2 have acquired and stably maintain many additional DHSs within the Th2 cytokine gene locus. These pDHSs persist in non-dividing CD4 memory T cells and are also observed in CD8 T blast cells (Figure (Figure4)4) and Th2 T cells (75). Because the vast majority of the ~3,000 CD4 T cell pDHSs were also detected in CD8 T blast cells, it is likely that the mechanism of chromatin priming seen here is a universal feature of T lineage cells (10). The significance of the presence of the pDHSs becomes obvious once it is recognized that the pDHSs are embedded within extensive active chromatin domains carrying the activating H3K4me2 and H3K27ac modifications (Figure (Figure4).4). Furthermore, these active domains encompass several iDHSs which are known to function as transcriptional enhancers (68). The inference here is that the pDHSs are functioning to render the adjacent enhancers more accessible, and therefore more responsive to TCR signaling. This is exemplified by the rapid recruitment of the AP-1 family TF JUNB in stimulated T-blast cells to iDHSs (Figures (Figures3C3C and and4).4). By contrast, these enhancers fail to form iDHSs in stimulated naïve CD4 T cells and thymocytes (Figure (Figure4),4), even though the AP-1 and NFAT mRNAs required for enhancer activation are efficiently expressed by activated naïve T cells (10, 23, 45).

Studies of the Human IL3/CSF2 Locus as a Model for Chromatin Priming

Alongside the IL2 and Th2 cytokine gene loci, the human IL3/CSF2 locus is one of the best studied models of inducible cytokine gene regulation in T cells. The use of transgenic mouse models in parallel with human and mouse cells has made it possible to investigate the developmental regulation, the inducible regulation, and the conservation of regulatory elements at this locus (10, 23, 45, 71, 7679). Analyses comparing thymocytes, spleen T cells, and T blast cells were central to the original identification of DNA priming elements associated with locus priming and transcriptional competency in T cells (23). Similar to the Th2 cytokine locus, the human IL3/CSF2 locus exists as a tract of greater than 100 kb of unmodified inactive chromatin in naïve T cells, and it acquires several pDHSs and active chromatin domains during T blast cell transformation. Following blast cell transformation, several iDHSs which function as promoters and enhancers can then be induced within the region (10). Consistent with what we observed at the human locus, the mouse Il3/Csf2 locus showed conservation of most of the pDHSs and iDHSs, and in this case the inactive chromatin domain spanned at least 220 kb in naïve mouse CD4 T cells (10). Parallel functional analyses of pDHSs in the IL3/CSF2 locus revealed that, as a general rule, pDHSs, unlike iDHSs, tend not to function directly as transcriptional enhancers but as DNA elements that may be required to maintain zones of activating histone methylation and acetylation (23, 45). Along with similar observations made by others, the body of evidence now indicates that the mere presence of active chromatin modifications at DHSs is not in itself sufficient to predict enhancer function (80), even though this remains a popular assumption.

The above studies also suggested that, once established in response to TCR activation, pDHSs were stably maintained in actively dividing T cells in the presence of IL-2, and were temporally stable in circulating human T cells for what must be assumed to be decades (10, 23). What remains to be seen is whether ETS and RUNX TFs remain bound to chromatin during mitosis, as seen for GATA1 which functions as a mitotic bookmarking factor in erythroid lineage cells (81).

We confirmed that pDHSs can indeed cooperate functionally with inducible enhancers by deleting the human IL3 −34 kb pDHS from its natural context in Jurkat T cells. This deletion led to a marked decrease in chromatin accessibility at the nearby −37 kb IL3 enhancer, in parallel with a change in kinetics of IL3 mRNA induction from a pattern resembling that seen in memory T cells (as in Figure Figure1B)1B) to a pattern resembling that seen in naïve T cells (as in Figure Figure1C)1C) (10). From these studies, it was apparent that pDHSs did indeed function locally at the level of chromatin accessibility, and globally there was a trend for pDHSs to reside within 25 kb of iDHSs at inducible loci (10). The most highly inducible genes were also found to be the loci where pDHSs and iDHSs were the closest, independently of their distance from the inducible promoters that they controlled.

A Hit-and-Run Model of Immunological Memory in T Cells

Taken together, these observations support a hit-and-run model for the initial establishment of epigenetic priming during T blast cell transformation which is predicted to alter chromatin accessibility (10) (Figure (Figure5).5). Within the nucleus, most chromatin is thought to be compacted into condensed structures ~110 to 170 nm in diameter (82), which is roughly fivefold greater than the classical 30 nm diameter solenoidal structure depicted at the bottom of Figure Figure5.5. Many immune response genes lie within large tracts of unmodified and inaccessible chromatin in thymocytes and naïve T cells, and this is likely to present a formidable barrier to inducible TF binding. Therefore, although ETS-1 and RUNX1 are already bound to the constitutive DHSs shared by naïve T cells and T blast cells (10), we believe that the chromatin harboring pDHSs is simply inaccessible to these TFs in naïve T cells. It is only after an extended period of TCR signaling and Brg1-dependent chromatin remodeling that the combined actions of AP-1, ETS-1, and RUNX1 are sufficient to open up pDHSs and modify the surrounding chromatin. This process of de novo DHS creation will also be considerably enhanced by the actions of NFAT and AP-1 at the adjacent enhancers during blast cell transformation. These factors are thought to be powerful drivers of chromatin opening and remodeling (24, 78). Once activated, the pDHSs are presumably maintained due to the high density of constitutive TF-binding sites, and consequently the surrounding chromatin is continuously remodeled and rendered more accessible. This more active chromatin structure may enable the primed immune response genes to more rapidly re-engage AP-1 and other inducible factors at both pDHSs and iDHSs when the cells are re-challenged. Furthermore, the presence of extensive histone acetylation and methylation is likely to make these chromatin domains even more accessible and the nucleosomes more mobile. This view is supported by the fact that the iDHS at the GM-CSF enhancer is strongly induced in just 20 min in T blast cells (78), but this and many other iDHSs remain undetectable even after 4 h of stimulation in naïve T cells and thymocytes (10, 23, 45). The binding of RUNX1 to the GM-CSF enhancer (83), and other iDHSs (10), is also controlled at the level of chromatin accessibility, because RUNX1 binding is only observed after the DHS has been induced. Because pDHSs exist in both CD4 and CD8 T blast cells, the hit-and-run epigenetic priming model presented in Figure Figure5,5, and exemplified in Figure Figure4,4, is likely to be a universal component of immunological memory in T lineage cells. Another important feature of this model of chromatin priming is that pDHSs allow genes to remain in a poised state with essentially no change in steady-state levels of transcription of primed loci in primed cells as compared to naïve T cells (10, 18). An analysis of the IL3/CSF2 locus also found that pDHSs do not recruit RNA Pol II or generate non-coding transcripts in the absence of stimulation (23).

Figure 5
Chromatin priming in T cells supports a rapid recall response. This model represents a closed chromatin domain, resembling that seen in Figure Figure4,4, which undergoes epigenetic priming in T blast cells to maintain an accessible active chromatin ...

The Role of Chromatin Priming in Supporting T Cell Differentiation

We find that many immune response genes, such as CSF2 and IL3, reach their full potential for transcriptional activation during the initial blast cell transformation, showing little difference in inducible mRNA expression between undifferentiated T blast cells and Th1 or Th2 cells, or between CD4 and CD8 T blast cells (23). However, other genes, such as IL4 and IFNγ, are primed during blast cell transformation but are only expressed at peak levels following further differentiation in the presence of polarizing cytokines, as depicted in Figure Figure1A.1A. For the purpose of this review, we performed additional analyses of public data sets with a view to identifying other functions for pDHSs at later stages of T cell differentiation. We observed that subsets of the pDHSs that are formed during blast cell transformation are predicted to subsequently play additional roles in supporting the gene regulation networks that are established by newly induced master regulator TFs under polarizing cytokine gene conditions, as depicted in Figure Figure6A.6A. Although pDHSs arise prior to helper T cell differentiation, some of these pDHSs, such as those seen in the Th2 cytokine gene locus, encompass GATA motifs (Figure (Figure3D).3D). For example, the Rad50 +52 kb DHS in the Th2 LCR encompasses three GATA motifs (10), and many of the pDHSs in this locus recruit GATA3 after Th2 differentiation (Figure (Figure77A).

Figure 6
Chromatin priming in undifferentiated CD4 T cells creates open chromatin at regions encompassing binding sites for differentiation-inducing transcription factors. (A) Schematic of differentiation pathways leading to type 1 helper (Th1), type 2 helper ...
Figure 7
Chromatin profiling of genes which are primed during blast cell transformation for subsequent binding of differentiation-inducing transcription factors. Shown here are the previously defined profiles for the mouse type 2 helper (Th2) cytokine gene cluster ...

To investigate the role of pDHSs in Th differentiation on a more global scale, we looked for the overlap between the 2,882 pDHSs that we defined in CD4 T blasts cells and the previously defined ChIP-Seq peaks taken from published studies of (i) GATA3 in Th2 cells, (ii) TBX21 in Th1 cells, and (iii) RORγ in Th17 cells (Figures (Figures6B,C).6B,C). Significantly, we found that 23% of the pDHSs were capable of recruiting TBX21, and 42% of the pDHSs were capable of recruiting GATA3 following differentiation.

To compare the relationship between pDHSs and the polarized mRNA expression patterns in differentiated cells (Figure (Figure6A),6A), we also compared the above ChIP-Seq and pDHS data with published mRNA data for the same cell types (Figure (Figure6C).6C). This allowed us to identify clear examples where elevated mRNA profiles were matched by recruitment of polarizing TFs to pDHSs. Hence, pDHSs recruit GATA3 to Il4 and Ccl1 in Th2 cells, TBX21 to Gzmb in Th1 cells, and RORγ to IL23r and Il17ra in Th17 cells. Interestingly, Th1 cells are closely related to Th17 cells, and we see a distinct overlap in the pDHS and ChIP-Seq profiles at genes such as Ifgr1 and Il12rb2 which are upregulated in both Th1 and Th17 cells (Figure (Figure6C).6C). Additional examples of specific pDHSs associated with locus polarization can be seen in Figure Figure7B7B where GATA3 is recruited to pDHSs within the Ccl1 locus in Th2 cells, and in Figure Figure7C7C where TBX21 and/or RORγ are recruited to pDHSs within the Il12rb2/Il23r locus following Th1 or Th17 differentiation.

The Requirement for Cytokine Signaling to Reinforce Immunological Memory

Despite the apparently stable nature of priming at pDHSs, it is well established that the maintenance of acquired immunity is itself highly dependent upon continual reinforcement from various cytokine and TNF receptor super family (TNFRSF) signaling networks (9194). The requirement for gamma chain cytokines, particularly interleukin 7 (IL-7), for the survival of naïve and memory T cells is well documented (95, 96). Memory CD4 T cells were initially divided into two subsets based on their expression of molecules enabling recirculation through lymph nodes (a CCR7 and CD62L-dependent process) and their cytokine profile after restimulation (97, 98). The term “central memory” described those CD4 T cells that expressed CCR7 and so could traffic through lymph nodes, but produced mostly IL-2 in the absence of effector cytokines; “effector memory” defined those cells lacking expression of CCR7, but able to rapidly produce effector cytokines such as IFNγ upon restimulation (97, 98). Thus memory CD4 T cell populations appear to divide the labor of surveying the periphery for signs of re-infection, while also being positioned to re-expand T cell populations within secondary lymphoid tissue and support other adaptive immune cells. More recently, analysis of endogenous Ag-specific memory CD4 T cells generated in a systemic Th1 response has provided data consistent with this nomenclature. Tracking 2W1S-specific responses induced by attenuated Listeria monocytogenes, the CCR7−CXCR5− memory population rapidly produced IFNγ and IL-2, but only gave rise to more effector memory cells, while the CCR7+CXCR5+ cells generated mostly IL-2 but could generate both effector and follicular CD4 T cell subsets (99). There is evidence that Th1 effector memory cells are dependent on signaling through the TNF receptor super family protein OX40 (TNFRSF4) (100, 101). Furthermore, an OX40-deficient human has been described (91), who had no in vitro detectable recall responses, while nevertheless clearly being able to control most infections. Strikingly, despite being vaccinated three times with live attenuated BCG vaccine, no detectable in vitro or in vivo responses were detected, although the patient did not succumb to BCG disease. This phenotype of failing to mount rapid recall responses indicates a lack of, or impairment within the effector memory cell compartment. Mice in which OX40 is lacking show a similar defect in CD4 T cell recall responses (93, 102). Interestingly, Ag-experienced T cells rapidly respond to IL-7 ex vivo to upregulate expression of OX40, a process that does not occur in naïve CD4 T cells (93), suggesting that priming of the OX40 locus is maintained in these cells. The accumulated evidence from OX40-deficient humans and mice would suggest that in, for example, an activated lymph node where Ag-presenting cells were induced to express OX40-ligand (TNFSF4), engagement of OX40 on IL-7-stimulated memory CD4 T cells would facilitate rapid responses to Ag re-exposure to produce effector cytokines (Figure (Figure88A).

Figure 8
The role of receptor signaling in immunological memory. (A) Long-term immunological memory in CD4 T cells is dependent on cytokine and TNFSF networks involving interleukin 7 (IL-7) and OX40 that maintain the rapid recall response in CD4 memory T cells. ...

Taken together, these observations raise the additional prospect that various alternative signaling pathways, which are required for the survival of memory T cells, could be involved in maintaining the pDHSs in the absence of TCR activation (Figure (Figure8B).8B). Once pDHSs have been created in response to AP-1 via TCR signaling, these same sites may be reinforced by intermittent recruitment of AP-1 and/or STAT family proteins, or other inducible factors which are activated by IL-7 or TNFRSF signals (103107) (Figure (Figure8B).8B). Indeed, motif analyses showed that STAT and AP-1 sites are enriched within the pDHSs (Figure (Figure3D)3D) and footprinting data suggests that some of the STAT sites are bound in the memory T cells (10). Furthermore, this view is supported by the in vitro experiments using the actively dividing T blast cells cultured with IL-2 which also have STAT and AP-1 sites footprinted in the pDHSs (10). Since these cells were constantly exposed to the gamma chain cytokine IL-2, which is closely related to IL-7, it seems that the activation of STAT5 and induction of AP-1 downstream of these signals may be a common mechanism to maintain the pDHSs in an open conformation in both the actively proliferating T blast cells and the quiescent memory T cells.

Another intriguing possibility is that STAT5 is acting as a molecular “bookmark” which is later replaced by STAT4, STAT6, or STAT3 when the cells are exposed to changes in signals and polarized to either Th1, Th2, or Th17 cells. An alternative, although not mutually exclusive, hypothesis is that STAT5 could be working as a transcriptional repressor. Studies in B cells have shown that STAT5 binding is associated with the prevention of immunoglobulin kappa light chain recombination via a block in E2A binding and also through recruitment of the histone methyltransferase EZH2 (108, 109). STAT5 could, therefore, be interacting with the pDHSs to suppress gene expression while maintaining a primed conformation for when the cells are re-activated.

Concluding Statement

Taken together, these studies suggest a model whereby immunological memory is maintained by epigenetic reprogramming which is first established via TCR signaling, then maintained by growth factors such as IL-2 and IL-7 during a proliferative response in activated T cells, and finally maintained by a cytokine network linked to TNFRSF signaling molecules in quiescent memory T cells (Figure (Figure9).9). The key to this model is that tight regulation observed at many immune response genes is mediated largely at the level of chromatin accessibility, and acquired immunity is likely to require regular reinforcement of the mechanisms that maintain accessibility. Importantly, the epigenetic priming that underpins acquired immunity in T cells is maintained by a specific class of regulatory elements, distinct from conventional transcriptional enhancers, that function primarily to maintain active chromatin rather than directly activating transcription.

Figure 9
Hypothetical model of a gene locus which is stably primed in memory T cells. In this model, T cell receptor (TCR) signaling initially establishes priming at primed DHSs (pDHSs) which is regularly reinforced when T cells are exposed to cytokine and/or ...

Public Data from the Gene Expression Omnibus Used in the Analyses Described Here

In addition to multiple data sets defined by Bevington et al., this article describes

  • Mouse Th1 mRNA GSM1182981, GSM1182982 (87).
  • Mouse Th17 mRNA GSM1182977, GSM1182978 (87).
  • Mouse Th2 mRNA GSM1194889 (88).
  • Mouse Th2 GATA3 ChIP-Seq GSM523226 (84).
  • Mouse Th1 TBX21 ChIP-Seq GSM998272 (85).
  • Mouse Th17 RORγ ChIP-Seq GSM1004856 (86).
  • Mouse spleen CTCF ChIP-Seq GSM918745 (74).
  • Mouse Th1 DNase-Seq GSM836117 (89).
  • Mouse Th2 ATAC-Seq GSM2056326 (90).

Author Contributions

SB, PC, and PNC analyzed the data and SB, DW, PL, and PNC wrote the manuscript.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Acknowledgments

The authors thank C. Bonifer, S. Ott, and N. Lalli for their input; and the BBSRC, the MRC, and Bloodwise for supporting the work underlying the studies described in this article. The authors thank D. Littman and S. Turner for sharing data that helped us to develop the models described here.

References

1. Swain SL, Croft M, Dubey C, Haynes L, Rogers P, Zhang X, et al. From naive to memory T cells. Immunol Rev (1996) 150:143–67.10.1111/j.1600-065X.1996.tb00700.x [PubMed] [Cross Ref]
2. Pihlgren M, Dubois PM, Tomkowiak M, Sjogren T, Marvel J.. Resting memory CD8+ T cells are hyperreactive to antigenic challenge in vitro. J Exp Med (1996) 184(6):2141–51.10.1084/jem.184.6.2141 [PMC free article] [PubMed] [Cross Ref]
3. Dubey C, Croft M, Swain SL.. Naive and effector CD4 T cells differ in their requirements for T cell receptor versus costimulatory signals. J Immunol (1996) 157(8):3280–9. [PubMed]
4. Curtsinger JM, Lins DC, Mescher MF.. CD8+ memory T cells (CD44high, Ly-6C+) are more sensitive than naive cells to (CD44low, Ly-6C-) to TCR/CD8 signaling in response to antigen. J Immunol (1998) 160(7):3236–43. [PubMed]
5. Rogers PR, Dubey C, Swain SL.. Qualitative changes accompany memory T cell generation: faster, more effective responses at lower doses of antigen. J Immunol (2000) 164(5):2338–46.10.4049/jimmunol.164.5.2338 [PubMed] [Cross Ref]
6. Kaech SM, Wherry EJ, Ahmed R.. Effector and memory T-cell differentiation: implications for vaccine development. Nat Rev Immunol (2002) 2(4):251–62.10.1038/nri778 [PubMed] [Cross Ref]
7. Sprent J, Surh CD.. T cell memory. Annu Rev Immunol (2002) 20:551–79.10.1146/annurev.immunol.20.100101.151926 [PubMed] [Cross Ref]
8. Zediak VP, Wherry EJ, Berger SL.. The contribution of epigenetic memory to immunologic memory. Curr Opin Genet Dev (2011) 21(2):154–9.10.1016/j.gde.2011.01.016 [PubMed] [Cross Ref]
9. Weng NP, Araki Y, Subedi K.. The molecular basis of the memory T cell response: differential gene expression and its epigenetic regulation. Nat Rev Immunol (2012) 12(4):306–15.10.1038/nri3173 [PMC free article] [PubMed] [Cross Ref]
10. Bevington SL, Cauchy P, Piper J, Bertrand E, Lalli N, Jarvis RC, et al. Inducible chromatin priming is associated with the establishment of immunological memory in T cells. EMBO J (2016) 35(5):515–35.10.15252/embj.201592534 [PMC free article] [PubMed] [Cross Ref]
11. Chandok MR, Okoye FI, Ndejembi MP, Farber DL.. A biochemical signature for rapid recall of memory CD4 T cells. J Immunol (2007) 179(6):3689–98.10.4049/jimmunol.179.6.3689 [PubMed] [Cross Ref]
12. Kersh EN, Kaech SM, Onami TM, Moran M, Wherry EJ, Miceli MC, et al. TCR signal transduction in antigen-specific memory CD8 T cells. J Immunol (2003) 170(11):5455–63.10.4049/jimmunol.170.11.5455 [PubMed] [Cross Ref]
13. Nakayama T, Yamashita M.. Critical role of the polycomb and trithorax complexes in the maintenance of CD4 T cell memory. Semin Immunol (2009) 21(2):78–83.10.1016/j.smim.2009.02.001 [PubMed] [Cross Ref]
14. Hashimoto S, Ogoshi K, Sasaki A, Abe J, Qu W, Nakatani Y, et al. Coordinated changes in DNA methylation in antigen-specific memory CD4 T cells. J Immunol (2013) 190(8):4076–91.10.4049/jimmunol.1202267 [PMC free article] [PubMed] [Cross Ref]
15. Komori HK, Hart T, LaMere SA, Chew PV, Salomon DR.. Defining CD4 T cell memory by the epigenetic landscape of CpG DNA methylation. J Immunol (2015) 194(4):1565–79.10.4049/jimmunol.1401162 [PMC free article] [PubMed] [Cross Ref]
16. Jeltsch KM, Heissmeyer V.. Regulation of T cell signaling and autoimmunity by RNA-binding proteins. Curr Opin Immunol (2016) 39:127–35.10.1016/j.coi.2016.01.011 [PubMed] [Cross Ref]
17. Swanson BJ, Murakami M, Mitchell TC, Kappler J, Marrack P.. RANTES production by memory phenotype T cells is controlled by a posttranscriptional, TCR-dependent process. Immunity (2002) 17(5):605–15.10.1016/S1074-7613(02)00456-9 [PubMed] [Cross Ref]
18. Bevington SL, Cauchy P, Cockerill PN. Chromatin priming elements establish immunological memory in T cells without activating transcription: T cell memory is maintained by DNA elements which stably prime inducible genes without activating steady state transcription. Bioessays (2017) 39(2).10.1002/bies.201600184 [PubMed] [Cross Ref]
19. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol (1989) 7:145–73.10.1146/annurev.iy.07.040189.001045 [PubMed] [Cross Ref]
20. Kanhere A, Hertweck A, Bhatia U, Gokmen MR, Perucha E, Jackson I, et al. T-bet and GATA3 orchestrate Th1 and Th2 differentiation through lineage-specific targeting of distal regulatory elements. Nat Commun (2012) 3:1268.10.1038/ncomms2260 [PMC free article] [PubMed] [Cross Ref]
21. Zhu J, Yamane H, Paul WE.. Differentiation of effector CD4 T cell populations (*). Annu Rev Immunol (2010) 28:445–89.10.1146/annurev-immunol-030409-101212 [PMC free article] [PubMed] [Cross Ref]
22. Yamane H, Paul WE.. Early signaling events that underlie fate decisions of naive CD4(+) T cells toward distinct T-helper cell subsets. Immunol Rev (2013) 252(1):12–23.10.1111/imr.12032 [PMC free article] [PubMed] [Cross Ref]
23. Mirabella F, Baxter EW, Boissinot M, James SR, Cockerill PN.. The human IL-3/granulocyte-macrophage colony-stimulating factor locus is epigenetically silent in immature thymocytes and is progressively activated during T cell development. J Immunol (2010) 184(6):3043–54.10.4049/jimmunol.0901364 [PubMed] [Cross Ref]
24. Zhao K, Wang W, Rando OJ, Xue Y, Swiderek K, Kuo A, et al. Rapid and phosphoinositol-dependent binding of the SWI/SNF-like BAF complex to chromatin after T lymphocyte receptor signaling. Cell (1998) 95(5):625–36.10.1016/S0092-8674(00)81633-5 [PubMed] [Cross Ref]
25. Para A, Li Y, Marshall-Colon A, Varala K, Francoeur NJ, Moran TM, et al. Hit-and-run transcriptional control by bZIP1 mediates rapid nutrient signaling in Arabidopsis. Proc Natl Acad Sci U S A (2014) 111(28):10371–6.10.1073/pnas.1404657111 [PubMed] [Cross Ref]
26. Voss TC, Schiltz RL, Sung MH, Yen PM, Stamatoyannopoulos JA, Biddie SC, et al. Dynamic exchange at regulatory elements during chromatin remodeling underlies assisted loading mechanism. Cell (2011) 146(4):544–54.10.1016/j.cell.2011.07.006 [PMC free article] [PubMed] [Cross Ref]
27. Lamke J, Brzezinka K, Altmann S, Baurle I.. A hit-and-run heat shock factor governs sustained histone methylation and transcriptional stress memory. EMBO J (2016) 35(2):162–75.10.15252/embj.201592593 [PubMed] [Cross Ref]
28. D’Urso A, Brickner JH. Epigenetic transcriptional memory. Curr Genet (2016).10.1007/s00294-016-0661-8 [PubMed] [Cross Ref]
29. Rothenberg EV, Zhang JA.. T-cell identity and epigenetic memory. Curr Top Microbiol Immunol (2012) 356:117–43.10.1007/82_2011_168 [PMC free article] [PubMed] [Cross Ref]
30. Ostuni R, Piccolo V, Barozzi I, Polletti S, Termanini A, Bonifacio S, et al. Latent enhancers activated by stimulation in differentiated cells. Cell (2013) 152(1–2):157–71.10.1016/j.cell.2012.12.018 [PubMed] [Cross Ref]
31. Gross DS, Garrard WT. Nuclease hypersensitive sites in chromatin. Annu Rev Biochem (1988) 57:159–97.10.1146/annurev.bi.57.070188.001111 [PubMed] [Cross Ref]
32. Berger SL.. The complex language of chromatin regulation during transcription. Nature (2007) 447(7143):407–12.10.1038/nature05915 [PubMed] [Cross Ref]
33. Clapier CR, Cairns BR.. The biology of chromatin remodeling complexes. Annu Rev Biochem (2009) 78:273–304.10.1146/annurev.biochem.77.062706.153223 [PubMed] [Cross Ref]
34. Li B, Carey M, Workman JL.. The role of chromatin during transcription. Cell (2007) 128(4):707–19.10.1016/j.cell.2007.01.015 [PubMed] [Cross Ref]
35. Racki LR, Narlikar GJ.. ATP-dependent chromatin remodeling enzymes: two heads are not better, just different. Curr Opin Genet Dev (2008) 18(2):137–44.10.1016/j.gde.2008.01.007 [PMC free article] [PubMed] [Cross Ref]
36. Shahbazian MD, Grunstein M.. Functions of site-specific histone acetylation and deacetylation. Annu Rev Biochem (2007) 76:75–100.10.1146/annurev.biochem.76.052705.162114 [PubMed] [Cross Ref]
37. Cockerill PN.. Structure and function of active chromatin and DNase I hypersensitive sites. FEBS J (2011) 278(13):2182–210.10.1111/j.1742-4658.2011.08128.x [PubMed] [Cross Ref]
38. Suganuma T, Workman JL.. Crosstalk among histone modifications. Cell (2008) 135(4):604–7.10.1016/j.cell.2008.10.036 [PubMed] [Cross Ref]
39. Ernst J, Kheradpour P, Mikkelsen TS, Shoresh N, Ward LD, Epstein CB, et al. Mapping and analysis of chromatin state dynamics in nine human cell types. Nature (2011) 473(7345):43–9.10.1038/nature09906 [PMC free article] [PubMed] [Cross Ref]
40. Buenrostro JD, Giresi PG, Zaba LC, Chang HY, Greenleaf WJ.. Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nat Methods (2013) 10(12):1213–8.10.1038/nmeth.2688 [PMC free article] [PubMed] [Cross Ref]
41. Cockerill PN, Bonifer C. Chromatin structure profiling identifies crucial regulators of tumor maintenance. Trends Cancer (2015) 1(3):157–60.10.1016/j.trecan.2015.10.003 [Cross Ref]
42. Agarwal S, Rao A.. Modulation of chromatin structure regulates cytokine gene expression during T cell differentiation. Immunity (1998) 9(6):765–75.10.1016/S1074-7613(00)80642-1 [PubMed] [Cross Ref]
43. Vahedi G, Takahashi H, Nakayamada S, Sun HW, Sartorelli V, Kanno Y, et al. STATs shape the active enhancer landscape of T cell populations. Cell (2012) 151(5):981–93.10.1016/j.cell.2012.09.044 [PMC free article] [PubMed] [Cross Ref]
44. Wei L, Vahedi G, Sun HW, Watford WT, Takatori H, Ramos HL, et al. Discrete roles of STAT4 and STAT6 transcription factors in tuning epigenetic modifications and transcription during T helper cell differentiation. Immunity (2010) 32(6):840–51.10.1016/j.immuni.2010.06.003 [PMC free article] [PubMed] [Cross Ref]
45. Baxter EW, Mirabella F, Bowers SR, James SR, Bonavita AM, Bertrand E, et al. The inducible tissue-specific expression of the human IL-3/GM-CSF locus is controlled by a complex array of developmentally regulated enhancers. J Immunol (2012) 189(9):4459–69.10.4049/jimmunol.1201915 [PMC free article] [PubMed] [Cross Ref]
46. Araki Y, Wang Z, Zang C, Wood WH, III, Schones D, Cui K, et al. Genome-wide analysis of histone methylation reveals chromatin state-based regulation of gene transcription and function of memory CD8+ T cells. Immunity (2009) 30(6):912–25.10.1016/j.immuni.2009.05.006 [PMC free article] [PubMed] [Cross Ref]
47. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z, et al. High-resolution profiling of histone methylations in the human genome. Cell (2007) 129(4):823–37.10.1016/j.cell.2007.05.009 [PubMed] [Cross Ref]
48. Araki Y, Fann M, Wersto R, Weng NP.. Histone acetylation facilitates rapid and robust memory CD8 T cell response through differential expression of effector molecules (eomesodermin and its targets: perforin and granzyme B). J Immunol (2008) 180(12):8102–8.10.4049/jimmunol.180.12.8102 [PMC free article] [PubMed] [Cross Ref]
49. D’Urso A, Takahashi YH, Xiong B, Marone J, Coukos R, Randise-Hinchliff C, et al. Set1/COMPASS and mediator are repurposed to promote epigenetic transcriptional memory. Elife (2016) 5.10.7554/eLife.16691 [PMC free article] [PubMed] [Cross Ref]
50. Santos-Rosa H, Schneider R, Bannister AJ, Sherriff J, Bernstein BE, Emre NC, et al. Active genes are tri-methylated at K4 of histone H3. Nature (2002) 419(6905):407–11.10.1038/nature01080 [PubMed] [Cross Ref]
51. Crompton JG, Narayanan M, Cuddapah S, Roychoudhuri R, Ji Y, Yang W, et al. Lineage relationship of CD8(+) T cell subsets is revealed by progressive changes in the epigenetic landscape. Cell Mol Immunol (2016) 13(4):502–13.10.1038/cmi.2015.032 [PMC free article] [PubMed] [Cross Ref]
52. Onodera A, Yamashita M, Endo Y, Kuwahara M, Tofukuji S, Hosokawa H, et al. STAT6-mediated displacement of polycomb by trithorax complex establishes long-term maintenance of GATA3 expression in T helper type 2 cells. J Exp Med (2010) 207(11):2493–506.10.1084/jem.20100760 [PMC free article] [PubMed] [Cross Ref]
53. Russ BE, Olshanksy M, Smallwood HS, Li J, Denton AE, Prier JE, et al. Distinct epigenetic signatures delineate transcriptional programs during virus-specific CD8(+) T cell differentiation. Immunity (2014) 41(5):853–65.10.1016/j.immuni.2014.11.001 [PMC free article] [PubMed] [Cross Ref]
54. Wei G, Wei L, Zhu J, Zang C, Hu-Li J, Yao Z, et al. Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. Immunity (2009) 30(1):155–67.10.1016/j.immuni.2008.12.009 [PMC free article] [PubMed] [Cross Ref]
55. Yamashita M, Hirahara K, Shinnakasu R, Hosokawa H, Norikane S, Kimura MY, et al. Crucial role of MLL for the maintenance of memory T helper type 2 cell responses. Immunity (2006) 24(5):611–22.10.1016/j.immuni.2006.03.017 [PubMed] [Cross Ref]
56. Yamashita M, Shinnakasu R, Nigo Y, Kimura M, Hasegawa A, Taniguchi M, et al. Interleukin (IL)-4-independent maintenance of histone modification of the IL-4 gene loci in memory Th2 cells. J Biol Chem (2004) 279(38):39454–64.10.1074/jbc.M405989200 [PubMed] [Cross Ref]
57. Youngblood B, Davis CW, Ahmed R.. Making memories that last a lifetime: heritable functions of self-renewing memory CD8 T cells. Int Immunol (2010) 22(10):797–803.10.1093/intimm/dxq437 [PMC free article] [PubMed] [Cross Ref]
58. Kersh EN, Fitzpatrick DR, Murali-Krishna K, Shires J, Speck SH, Boss JM, et al. Rapid demethylation of the IFN-gamma gene occurs in memory but not naive CD8 T cells. J Immunol (2006) 176(7):4083–93.10.4049/jimmunol.176.7.4083 [PubMed] [Cross Ref]
59. Northrop JK, Wells AD, Shen H.. Cutting edge: chromatin remodeling as a molecular basis for the enhanced functionality of memory CD8 T cells. J Immunol (2008) 181(2):865–8.10.4049/jimmunol.181.2.865 [PubMed] [Cross Ref]
60. Dispirito JR, Shen H.. Histone acetylation at the single-cell level: a marker of memory CD8+ T cell differentiation and functionality. J Immunol (2010) 184(9):4631–6.10.4049/jimmunol.0903830 [PubMed] [Cross Ref]
61. Fitzpatrick DR, Shirley KM, Kelso A.. Cutting edge: stable epigenetic inheritance of regional IFN-gamma promoter demethylation in CD44highCD8+ T lymphocytes. J Immunol (1999) 162(9):5053–7. [PubMed]
62. Youngblood B, Hale JS, Ahmed R.. T-cell memory differentiation: insights from transcriptional signatures and epigenetics. Immunology (2013) 139(3):277–84.10.1111/imm.12074 [PubMed] [Cross Ref]
63. Gray SM, Kaech SM, Staron MM. The interface between transcriptional and epigenetic control of effector and memory CD8(+) T-cell differentiation. Immunol Rev (2014) 261(1):157–68.10.1111/imr.12205 [PMC free article] [PubMed] [Cross Ref]
64. Northrop JK, Thomas RM, Wells AD, Shen H.. Epigenetic remodeling of the IL-2 and IFN-gamma loci in memory CD8 T cells is influenced by CD4 T cells. J Immunol (2006) 177(2):1062–9.10.4049/jimmunol.177.2.1062 [PubMed] [Cross Ref]
65. Light WH, Freaney J, Sood V, Thompson A, D’Urso A, Horvath CM, et al. A conserved role for human Nup98 in altering chromatin structure and promoting epigenetic transcriptional memory. PLoS Biol (2013) 11(3):e1001524.10.1371/journal.pbio.1001524 [PMC free article] [PubMed] [Cross Ref]
66. Baxter EW, Cummings WJ, Fournier RE.. Formation of a large, complex domain of histone hyperacetylation at human 14q32.1 requires the serpin locus control region. Nucleic Acids Res (2005) 33(10):3313–22.10.1093/nar/gki645 [PMC free article] [PubMed] [Cross Ref]
67. Hawwari A, Burrows J, Vadas MA, Cockerill PN.. The human IL-3 locus is regulated cooperatively by two NFAT-dependent enhancers that have distinct tissue-specific activities. J Immunol (2002) 169(4):1876–86.10.4049/jimmunol.169.4.1876 [PubMed] [Cross Ref]
68. Lee GR, Fields PE, Flavell RA.. Regulation of IL-4 gene expression by distal regulatory elements and GATA-3 at the chromatin level. Immunity (2001) 14(4):447–59.10.1016/S1074-7613(01)00125-X [PubMed] [Cross Ref]
69. Chen L, Glover JN, Hogan PG, Rao A, Harrison SC.. Structure of the DNA-binding domains from NFAT, Fos and Jun bound specifically to DNA. Nature (1998) 392(6671):42–8.10.1038/32100 [PubMed] [Cross Ref]
70. Cockerill PN, Bert AG, Jenkins F, Ryan GR, Shannon MF, Vadas MA. Human GM-CSF enhancer function is associated with cooperative interactions between AP-1 and NFATp/c. Mol Cell Biol (1995) 15(4):2071–9.10.1128/MCB.15.4.2071 [PMC free article] [PubMed] [Cross Ref]
71. Bowers SR, Mirabella F, Calero-Nieto FJ, Valeaux S, Hadjur S, Baxter EW, et al. A conserved insulator that recruits CTCF and cohesin exists between the closely related but divergently regulated interleukin-3 and granulocyte-macrophage colony-stimulating factor genes. Mol Cell Biol (2009) 29(7):1682–93.10.1128/MCB.01411-08 [PMC free article] [PubMed] [Cross Ref]
72. Lee GR, Spilianakis CG, Flavell RA.. Hypersensitive site 7 of the TH2 locus control region is essential for expressing TH2 cytokine genes and for long-range intrachromosomal interactions. Nat Immunol (2005) 6(1):42–8.10.1038/ni1148 [PubMed] [Cross Ref]
73. Lee GR, Fields PE, Griffin TJ, Flavell RA.. Regulation of the Th2 cytokine locus by a locus control region. Immunity (2003) 19(1):145–53.10.1016/S1074-7613(03)00179-1 [PubMed] [Cross Ref]
74. Yue F, Cheng Y, Breschi A, Vierstra J, Wu W, Ryba T, et al. A comparative encyclopedia of DNA elements in the mouse genome. Nature (2014) 515(7527):355–64.10.1038/nature13992 [PMC free article] [PubMed] [Cross Ref]
75. Fields PE, Lee GR, Kim ST, Bartsevich VV, Flavell RA.. Th2-specific chromatin remodeling and enhancer activity in the Th2 cytokine locus control region. Immunity (2004) 21(6):865–76.10.1016/j.immuni.2004.10.015 [PubMed] [Cross Ref]
76. Bert AG, Johnson BV, Baxter EW, Cockerill PN.. A modular enhancer is differentially regulated by GATA and NFAT elements that direct different tissue-specific patterns of nucleosome positioning and inducible chromatin remodeling. Mol Cell Biol (2007) 27(8):2870–85.10.1128/MCB.02323-06 [PMC free article] [PubMed] [Cross Ref]
77. Cockerill PN, Shannon MF, Bert AG, Ryan GR, Vadas MA.. The granulocyte-macrophage colony-stimulating factor/interleukin 3 locus is regulated by an inducible cyclosporin A-sensitive enhancer. Proc Natl Acad Sci U S A (1993) 90(6):2466–70.10.1073/pnas.90.6.2466 [PubMed] [Cross Ref]
78. Johnson BV, Bert AG, Ryan GR, Condina A, Cockerill PN. GM-CSF enhancer activation requires cooperation between NFAT and AP-1 elements and is associated with extensive nucleosome reorganization. Mol Cell Biol (2004) 24(18):7914–30.10.1128/MCB.24.18.7914-7930.2004 [PMC free article] [PubMed] [Cross Ref]
79. Osborne CS, Vadas MA, Cockerill PN.. Transcriptional regulation of mouse granulocyte-macrophage colony-stimulating factor/IL-3 locus. J Immunol (1995) 155(1):226–35. [PubMed]
80. Kwasnieski JC, Fiore C, Chaudhari HG, Cohen BA.. High-throughput functional testing of ENCODE segmentation predictions. Genome Res (2014) 24(10):1595–602.10.1101/gr.173518.114 [PubMed] [Cross Ref]
81. Kadauke S, Udugama MI, Pawlicki JM, Achtman JC, Jain DP, Cheng Y, et al. Tissue-specific mitotic bookmarking by hematopoietic transcription factor GATA1. Cell (2012) 150(4):725–37.10.1016/j.cell.2012.06.038 [PMC free article] [PubMed] [Cross Ref]
82. Kireev I, Lakonishok M, Liu W, Joshi VN, Powell R, Belmont AS.. In vivo immunogold labeling confirms large-scale chromatin folding motifs. Nat Methods (2008) 5(4):311–3.10.1038/nmeth.1196 [PubMed] [Cross Ref]
83. Bowers SR, Calero-Nieto FJ, Valeaux S, Fernandez-Fuentes N, Cockerill PN.. Runx1 binds as a dimeric complex to overlapping Runx1 sites within a palindromic element in the human GM-CSF enhancer. Nucleic Acids Res (2010) 38:6124–34.10.1093/nar/gkq356 [PMC free article] [PubMed] [Cross Ref]
84. Wei G, Abraham BJ, Yagi R, Jothi R, Cui K, Sharma S, et al. Genome-wide analyses of transcription factor GATA3-mediated gene regulation in distinct T cell types. Immunity (2011) 35(2):299–311.10.1016/j.immuni.2011.08.007 [PMC free article] [PubMed] [Cross Ref]
85. Gokmen MR, Dong R, Kanhere A, Powell N, Perucha E, Jackson I, et al. Genome-wide regulatory analysis reveals that T-bet controls Th17 lineage differentiation through direct suppression of IRF4. J Immunol (2013) 191(12):5925–32.10.4049/jimmunol.1202254 [PMC free article] [PubMed] [Cross Ref]
86. Ciofani M, Madar A, Galan C, Sellars M, Mace K, Pauli F, et al. A validated regulatory network for Th17 cell specification. Cell (2012) 151(2):289–303.10.1016/j.cell.2012.09.016 [PMC free article] [PubMed] [Cross Ref]
87. Ichiyama K, Chen T, Wang X, Yan X, Kim BS, Tanaka S, et al. The methylcytosine dioxygenase Tet2 promotes DNA demethylation and activation of cytokine gene expression in T cells. Immunity (2015) 42(4):613–26.10.1016/j.immuni.2015.03.005 [PMC free article] [PubMed] [Cross Ref]
88. Lin CC, Bradstreet TR, Schwarzkopf EA, Sim J, Carrero JA, Chou C, et al. Bhlhe40 controls cytokine production by T cells and is essential for pathogenicity in autoimmune neuroinflammation. Nat Commun (2014) 5:3551.10.1038/ncomms4551 [PMC free article] [PubMed] [Cross Ref]
89. Nakayamada S, Kanno Y, Takahashi H, Jankovic D, Lu KT, Johnson TA, et al. Early Th1 cell differentiation is marked by a Tfh cell-like transition. Immunity (2011) 35(6):919–31.10.1016/j.immuni.2011.11.012 [PMC free article] [PubMed] [Cross Ref]
90. Shih HY, Sciume G, Mikami Y, Guo L, Sun HW, Brooks SR, et al. Developmental acquisition of regulomes underlies innate lymphoid cell functionality. Cell (2016) 165(5):1120–33.10.1016/j.cell.2016.04.029 [PMC free article] [PubMed] [Cross Ref]
91. Byun M, Ma CS, Akcay A, Pedergnana V, Palendira U, Myoung J, et al. Inherited human OX40 deficiency underlying classic Kaposi sarcoma of childhood. J Exp Med (2013) 210(9):1743–59.10.1084/jem.20130592 [PMC free article] [PubMed] [Cross Ref]
92. Gaspal F, Bekiaris V, Kim MY, Withers DR, Bobat S, MacLennan IC, et al. Critical synergy of CD30 and OX40 signals in CD4 T cell homeostasis and Th1 immunity to Salmonella. J Immunol (2008) 180(5):2824–9.10.4049/jimmunol.180.5.2824 [PubMed] [Cross Ref]
93. Gaspal FM, Kim MY, McConnell FM, Raykundalia C, Bekiaris V, Lane PJ.. Mice deficient in OX40 and CD30 signals lack memory antibody responses because of deficient CD4 T cell memory. J Immunol (2005) 174(7):3891–6.10.4049/jimmunol.174.7.3891 [PubMed] [Cross Ref]
94. Seddon B, Tomlinson P, Zamoyska R.. Interleukin 7 and T cell receptor signals regulate homeostasis of CD4 memory cells. Nat Immunol (2003) 4(7):680–6.10.1038/ni946 [PubMed] [Cross Ref]
95. Surh CD, Sprent J. Homeostasis of naive and memory T cells. Immunity (2008) 29(6):848–62.10.1016/j.immuni.2008.11.002 [PubMed] [Cross Ref]
96. Osborne LC, Abraham N. Regulation of memory T cells by gammac cytokines. Cytokine (2010) 50(2):105–13.10.1016/j.cyto.2009.09.008 [PubMed] [Cross Ref]
97. Sallusto F, Geginat J, Lanzavecchia A.. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol (2004) 22:745–63.10.1146/annurev.immunol.22.012703.104702 [PubMed] [Cross Ref]
98. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A.. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature (1999) 401(6754):708–12.10.1038/44385 [PubMed] [Cross Ref]
99. Pepper M, Pagan AJ, Igyarto BZ, Taylor JJ, Jenkins MK. Opposing signals from the Bcl6 transcription factor and the interleukin-2 receptor generate T helper 1 central and effector memory cells. Immunity (2011) 35(4):583–95.10.1016/j.immuni.2011.09.009 [PMC free article] [PubMed] [Cross Ref]
100. Yamaki S, Ine S, Kawabe T, Okuyama Y, Suzuki N, Soroosh P, et al. OX40 and IL-7 play synergistic roles in the homeostatic proliferation of effector memory CD4(+) T cells. Eur J Immunol (2014) 44(10):3015–25.10.1002/eji.201444701 [PubMed] [Cross Ref]
101. Marriott CL, Mackley EC, Ferreira C, Veldhoen M, Yagita H, Withers DR.. OX40 controls effector CD4+ T-cell expansion, not follicular T helper cell generation in acute Listeria infection. Eur J Immunol (2014) 44(8):2437–47.10.1002/eji.201344211 [PMC free article] [PubMed] [Cross Ref]
102. Kim MY, Gaspal FM, Wiggett HE, McConnell FM, Gulbranson-Judge A, Raykundalia C, et al. CD4(+)CD3(-) accessory cells costimulate primed CD4 T cells through OX40 and CD30 at sites where T cells collaborate with B cells. Immunity (2003) 18(5):643–54.10.1016/S1074-7613(03)00110-9 [PubMed] [Cross Ref]
103. Heltemes-Harris LM, Farrar MA.. The role of STAT5 in lymphocyte development and transformation. Curr Opin Immunol (2012) 24(2):146–52.10.1016/j.coi.2012.01.015 [PMC free article] [PubMed] [Cross Ref]
104. Ruppert SM, Chehtane M, Zhang G, Hu H, Li X, Khaled AR.. JunD/AP-1-mediated gene expression promotes lymphocyte growth dependent on interleukin-7 signal transduction. PLoS One (2012) 7(2):e32262.10.1371/journal.pone.0032262 [PMC free article] [PubMed] [Cross Ref]
105. Croft M.. Co-stimulatory members of the TNFR family: keys to effective T-cell immunity? Nat Rev Immunol (2003) 3(8):609–20.10.1038/nri1148 [PubMed] [Cross Ref]
106. Akiba H, Nakano H, Nishinaka S, Shindo M, Kobata T, Atsuta M, et al. CD27, a member of the tumor necrosis factor receptor superfamily, activates NF-kappaB and stress-activated protein kinase/c-Jun N-terminal kinase via TRAF2, TRAF5, and NF-kappaB-inducing kinase. J Biol Chem (1998) 273(21):13353–8.10.1074/jbc.273.21.13353 [PubMed] [Cross Ref]
107. Marsters SA, Ayres TM, Skubatch M, Gray CL, Rothe M, Ashkenazi A.. Herpesvirus entry mediator, a member of the tumor necrosis factor receptor (TNFR) family, interacts with members of the TNFR-associated factor family and activates the transcription factors NF-kappaB and AP-1. J Biol Chem (1997) 272(22):14029–32.10.1074/jbc.272.22.14029 [PubMed] [Cross Ref]
108. Malin S, McManus S, Cobaleda C, Novatchkova M, Delogu A, Bouillet P, et al. Role of STAT5 in controlling cell survival and immunoglobulin gene recombination during pro-B cell development. Nat Immunol (2010) 11(2):171–9.10.1038/ni.1827 [PMC free article] [PubMed] [Cross Ref]
109. Mandal M, Powers SE, Maienschein-Cline M, Bartom ET, Hamel KM, Kee BL, et al. Epigenetic repression of the Igk locus by STAT5-mediated recruitment of the histone methyltransferase Ezh2. Nat Immunol (2011) 12(12):1212–20.10.1038/ni.2136 [PMC free article] [PubMed] [Cross Ref]

Les articles de Frontiers in Immunology ont été offerts à titre gracieux par Frontiers Media SA.